MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202517010946 A) filed by Sinabiosolution Gmbh, Berlin, on Feb. 10, for 'humanized chimeric antigen receptors targeting the b-cell receptor of chronic lymphocytic leukemia and uses thereof.'
Inventor(s) include Duhren-Von Minden, Marcus; and Binder, Mascha.
The application for the patent was published on April 11, under issue no. 15/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides humanized chimeric antigen receptors (CARs) targeting the B-cell receptor (BCR) of CLL cells characterised by R110-mutated immunoglobulin lambda variable 3-21 (IGLV3-21R110). The invention also provides nucleic ac...